Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RIPAC trial: intravenous iron in preoperative management of anemia in colon cancer
2018-004213-41Phase 4Completed
- Sponsor
- Ghent University Hospital
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ferric carboxymaltose in colon cancer and iron deficiency anemia (IDA) (2 arms), sponsored by Ghent University Hospital. Primary endpoint: Mean hemoglobin increase at moment of surgery. Started May 2019; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
colon canceriron deficiency anemia (IDA)
Beyond the preview
Go deeper on 2018-004213-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004213-41.